Cosmos Pharmaceutical (3349.T)

Overall impact
B (60)

Commentary

Cosmos Pharmaceutical is a strong overall performer. With a 'B' rating of 60.3 for overall impact (63rd percentile compared to all companies), Cosmos Pharmaceutical ranks 6th out of 19 industry peers, behind HealthWarehouse.com, Trxade Group, Clicks Group and 2 others, and ahead of GNC, Petmed Express, Portfolio and 10 others. On top material causes for Cosmos Pharmaceutical's industry (Drug Retailers), Cosmos Pharmaceutical performs well in Reduced Use of tobacco (82.5 score) and Racial Justice and Civil Rights (89.0) and performs poorly in Child and Maternal Health (28.6 score) and No Violence Against Women (16.9).
Impact
Cause 3349.T
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1983
Employees
5,709
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Sub-industry
Drug Retail
SASB industry
Drug Retailers
Headquarters
Japan
Share classes
3349.T
Description
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, food, etc. in Japan. It also sells its products through online stores. The company was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
Material causes
Ethos considers the following causes material for Cosmos Pharmaceutical, based on its industry sub-industry Drug Retail. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.